Pharmafile Logo

Patient outcomes in practice: delivering value that transforms lives

June 11, 2018 |  

- PMLiVE
In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’.

In response to the increasing demands of global healthcare systems, pharma must demonstrate its value contribution. It is responding with patient-centric corporate missions, and patient outcomes-driven visions and initiatives, all with the aim of improving patient outcomes.

Dennis and Louise discuss how it’s no longer good enough to prove a commitment to patient outcomes, but instead we must demonstrate an impact. The programmes and initiatives that are incorporated into cross-functional plans all need to align to the same goal – so that we can then measure their impact against improving patient outcomes.

The vision is there, but it requires translation of this vision to execution of outcomes-led strategic planning, cross-functional alignment and metrics collection that transcend annual key performance indicator cycles. You can read more in the full article here

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A Stellar Start to 2021 for Lucid Group

It’s been a stellar start to 2021 for Lucid Group, which has welcomed 38 new starters into the company since the beginning of the year. These include 15 Client Services...

Day in a #LucidLife – Meet Philippa

Ever wondered what a #LucidLife looks like?Philippa McClure, Senior Account Director, takes us through her day. We have a number of roles in client services, just like Philippa's.So, if you like what...

My Journey into Medical Writing #LucidLife

In NetworkPharma’s latest career guide for wannabe medical writers, Jane Juif, Medical Writer, discusses her unconventional journey into the world of medical communications and medical writing.My journey into Med Comms...

LUCID GROUP PARTNERS WITH NEW INVESTOR ICG

Lucid Group has secured a new investment from Intermediate Capital Group (ICG) to support its continued ambition to build a global business that delivers life transforming value for everyone.Founded in...

IWD2021: #ChooseToChallenge Interview with Dennis O’Brien, Lucid Group CEO

Hey Dennis, what does this year’s IWD slogan, #ChooseToChallenge mean to you?I love it. It’s inspirational and action-oriented. It’s clear we need to change many things in our society, inequality...

Rare Disease Day in a COVID-19 environment

For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...

We Celebrate Your Whole Selves: That’s What Makes The Magic

People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...

Lucid Group: A Community of Purpose

In this month’s Pharmaceutical Marketing Europe, Lucid Group’s Chief People Officer, Angela Young, discusses the importance of bringing the company’s purpose to life so that its people feel connected to...

A magic milestone: Katherine’s 10-year workiversary

Katherine Duxbury recently celebrated the momentous and magical milestone of 10 years with Lucid Group – congratulations! Surprise virtual celebrations have been had and, while they were no replacement for...

Lucid Group – Let’s Start Talking

We can all help to transform the lives of those we touch by taking the time to talk and listen to one another. The power of conversation, sharing thoughts, worries...